• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SISTEMAS MEDICOS ALARIS S.A. DE C.V. BD ALARIS EXTENSION SET; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SISTEMAS MEDICOS ALARIS S.A. DE C.V. BD ALARIS EXTENSION SET; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 20129E
Medical Device Problem Code Filtration Problem (2941)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/10/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H.3.If a device evaluation and/or device history review is completed, a supplemental report will be filed.
 
Event or Problem Description
It was reported that bd alaris extension set was occluded the following information was received by the initial reporter with the following verbatim.Reported issue: lipid filter alarming occluded, filter replaced.
 
Additional Manufacturer Narrative
The customer reported the filter was clotted, and returned one used sample of material 20129e, lot unknown.The set was visually examined for defects and abnormalities.No defects or abnormalities were observed.The set was set up for a bubble test using 10 psi air pressure and submersing the set in water.This confirmed the filter was clogged, and the occlusion was confirmed.This bubble test is suggested by the filter supplier to test if the drugs/medication infused caused issues, or if the filter itself has a problem.The test confirmed that the occlusion was caused by the drugs/medication in the filter.The root cause is confirmed by bubble test to be the end user drugs/medications used.It is to be known that when lipids, tpn, or other nutrients are administered, the set should be swapped every 12 hrs.Check with clinical to determine the recommended time for a given medication when using filtered sets.This incident has been added to our database of reported incidents.Our business team regularly reviews the collected data for identification of emerging trends.Your assistance in this matter has been helpful in trend identification and supporting our commitment to continuous quality improvement.
 
Event or Problem Description
No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD ALARIS EXTENSION SET
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
SISTEMAS MEDICOS ALARIS S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer (Section G)
SISTEMAS MEDICOS ALARIS S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key19032245
Report Number9616066-2024-00515
Device Sequence Number12769787
Product Code FPA
UDI-Device Identifier10885403234903
UDI-Public(01)10885403234903
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K790108
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 11/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue Number20129E
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/12/2024
Supplement Date Received by Manufacturer11/04/2024
Initial Report FDA Received Date04/03/2024
Supplement Report FDA Received Date11/08/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-